Penn I.: Occurrence of cancer in immunodeficiencies. Cancer4:858-866, 1974
2.
Penn I.: Tumor incidence in human allograft recipients. Transplant Proc9:1047-1051, 1979
3.
Penn I.: Chemical immunosuppression and human cancer. Cancer34:1474-1480, 1974
4.
Bach JF: Immunosuppression. In, Hambuger J , Crosnier J, Bach JF, Kreis KH, eds: Renal Transplantation. Theory and Practice. Baltimore: Williams and Wilkins, 1981, pp 9-145
5.
Birkland SA : Cancer in transplant patients. The Scandia-transplant material. Transplant Proc15:1071-1078, 1983
6.
Penn I.: Development of cancer as a complication of clinical transplantation . Transplant Proc9:1121-1127, 1977
7.
Kinlen L., Doll R., Peto J.: The incidence of tumors in human transplant recipients. Transplant Proc15:1039-1042, 1983
8.
Lanza RP, Cooper DK, Cassidy MJ, Bernard CN: Malignant neoplasms occurring after cardiac transplantation. JAMA249:1746-1748, 1983
9.
Matas AJ, Simmons RL, Kjellstrand CM, et al: Increased incidence of malignancy in uremic patients and its significance to transplantation. Transplant Proc11:1137-1141, 1977
10.
Jacobs FP, Brunner FP, Brynger H., et al: Malignant diseases in patients treated by dialysis and transplantation in Europe. Transplant Proc13:729-732, 1981
11.
Sheil AG, Mahony JF, Howath JS, et al: Cancer following successful cadaveric donor renal transplantation . Transplant Proc13:733-735, 1981
12.
Axtell LM, Asire AJ, Myers MH, eds: Cancer Patient Survival Report Number 5 (Publication (NIH) 77-992). Washington DC: U.S. Government Printing Office, 1976, p 225
13.
Greene MH, Young TI, Clarke WH: Malignant melanoma in renal transplant recipients. Lancet1:1196-1198, 1981
14.
Fitzpatrick TB , Sober AJ, Mihm MC, Day CL: Malignant melanoma of skin. In, Petersdorf RF, Adams RD, Braunwald E, et al, eds: Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1983, pp 836-838
15.
Brunner FP, Brynger H., Chantler C., et al: Combined report on regular dialysis and transplantation in Europe . IX, 1978. Proc Eur Dial Transplant Assoc 16:2-73, 1979
16.
Linder A., Farewell VT, Sherrard DJ: High incidence of neoplasia in uremic patients receiving long term dialysis . Nephron27:292-296, 1981
17.
JU Gutterman , HI Scher: Melanoma. In, Holland JF, Frei E, eds: Cancer Medicine. Philadelphia: Lea and Febiger, 1981, pp 2109-2140
18.
Callery C., Cochran AJ, Roe JD, et al: Factors prognostic for survival in patients with malignant melanoma spread to regional lymph nodes. Ann Surg196:69-75, 1982
19.
Cady B.: Changing concepts in malignant melanoma. Med Clin North Am59:301-308, 1975
20.
Breslow A.: Tumor thickness, level of invasion, and node dissection in stage I cutaneous melanoma. Ann Surg182:572-575, 1975
21.
Lichtenfield JL: Malignant melanoma. Med Clin North Am61:1013-1025, 1977
22.
U.S. National Center for Health Statistics: Vital Statistics of the United States, annual. Washington DC: US Government Printing Office, 1975
23.
Beck JR, Kassirer JP, Pauker SG: A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med73:883-888, 1982
24.
Beck JR, Pauker SG, Gottlieb JE, et al: A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision making. Am J Med73:889-897, 1982
25.
Roberts SD, Maxwell DR, Gross TL: Cost-effective care of end-stage renal disease. A billion dollar question. Ann Intern Med92:243-248, 1980
26.
Weller JM, Port FK, Schwartz RD, et al: Analysis of survival of end-stage renal disease patients. Kidney Int21:78-83, 1982
27.
Wing AJ, Brunner FP, Brynger H., et al: Combined report on regular dialysis and transplantation in Europe. VIII, 1977. Proc Eur Dial Transplant Assoc16:2-76, 1978
28.
Vollmer WM, Wahl PW, Blagg CR: Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med308:1553-1558, 1983
29.
Krakauer H. , Grauman JS, McMullan MR, Creede CC: The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation . N Engl J Med308:1558-1563, 1983
30.
Opelz G., Mickey MR, Terasaki PI: Calculations on long-term graft and patient survival in human kidney transplantation . Transplant Proc9:27-30, 1977
31.
Crosnier J. , Rioux P., N'Guyen AT: Results of renal transplantation. In, Hamburger J, Crosnier J, Bach JF, Kreis KH, eds: Renal Transplantation. Theory and Practice. Baltimore: Williams and Wilkins, 1981, pp 268-282
32.
Hutchinson TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease. An age-equivalence index. Ann Intern Med96:417-423, 1982
33.
Blagg CR: Dialysis or transplantation. JAMA250:1072-1073, 1983
34.
Matas AJ, Tellis VA, Veith FJ, et al: The fate of the patient returned to hemodialysis after losing a renal transplant. JAMA250:1053-1056, 1983
35.
Gutman RA, Stead WW, Robinson RR: Physical activity and employment status of patients on maintenance dialysis . N Engl J Med304:309-313, 1981
36.
De-Nour AK, Shanan J.: Quality of life of dialysis and transplanted patients. Nephron25:117-120, 1980
37.
De-Nour AK: Social adjustment of chronic dialysis patients. Am J Psychiatry139:97-100,1982
38.
Johnson JP, McCauley CR, and Copley JB: The quality of life in hemodialysis and transplant patients. Kidney Int22:286-291, 1982
39.
Poznanski EO , Miller E., Salguero C., Kelsh RC: Quality of life for long-term survivors of end-stage renal disease. JAMA239:2343-2347, 1978
40.
Tversky A., Kahneman D.: The framing of decisions and the psychology of choice. Science211:453-458, 1981
41.
McNeil BJ, Pauker SG, Sox H., Tversky A.: On the elicitation of patient preference for alternative therapies . N Engl J Med306:1259-1262, 1982
42.
Pliskin JS, Shepard DS, Weinstein MC: Utility functions for life years and health status. Oper Res28:206-224, 1980
43.
Pauker SG, Beck JR, Kassirer JP: Risk adjustment and discounting in a bedside approximation of life expectancy (Abs). Med Decis Making2:351, 1982